PRQR logo

ProQR Therapeutics N.V.

PRQR
Healthcare|Biotechnology|NL
$1.35
+0.02 (+1.50%)
Tangible Book / Share
$0.72
Cash / Share
$1.06
Next Earnings Report
Mar 18, 2027
EPS est. -$0.13 · Revenue est. $4.1M
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Jul 15, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences
Oct 28, 2026 · GlobeNewsWire
ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor
Sep 23, 2026 · GlobeNewsWire
ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026
Sep 9, 2026 · GlobeNewsWire
ProQR to Participate in Upcoming Investor Conferences in September 2026
Sep 2, 2026 · GlobeNewsWire
ProQR Announces Second Quarter 2026 Operating and Financial Results
Aug 13, 2026 · GlobeNewsWire

SEC Filings (60)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 30, 20266-K/AForeign issuer reportDocumentIndex
Oct 28, 20266-KForeign issuer reportDocumentIndex
Sep 23, 20266-KForeign issuer reportDocumentIndex
Sep 9, 20266-KForeign issuer reportDocumentIndex
Aug 13, 20266-KForeign issuer reportDocumentIndex
Aug 13, 20266-KForeign issuer reportDocumentIndex
Jul 29, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jul 29, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 24, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 15, 2026EFFECTDocumentIndex
Jul 15, 2026424B5Offering prospectusDocumentIndex
Jul 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 6, 2026F-3Shelf registrationDocumentIndex
Jun 30, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 26, 20266-KForeign issuer reportDocumentIndex
Jun 26, 2026424B5Offering prospectusDocumentIndex
Jun 25, 20266-KForeign issuer reportDocumentIndex
Jun 3, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 2, 20266-KForeign issuer reportDocumentIndex
May 12, 20266-KForeign issuer reportDocumentIndex
May 12, 20266-KForeign issuer reportDocumentIndex
May 4, 20266-KForeign issuer reportDocumentIndex
Apr 30, 20266-KForeign issuer reportDocumentIndex
Apr 8, 20266-KForeign issuer reportDocumentIndex
Apr 8, 20266-KForeign issuer reportDocumentIndex
Mar 25, 20266-KForeign issuer reportDocumentIndex
Mar 12, 202620-FAnnual report (foreign)DocumentIndex
Mar 12, 20266-KForeign issuer reportDocumentIndex
Feb 9, 20266-KForeign issuer reportDocumentIndex
Feb 6, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jan 20, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 8, 20266-KForeign issuer reportDocumentIndex
Nov 6, 20256-KForeign issuer reportDocumentIndex
Nov 3, 20256-KForeign issuer reportDocumentIndex
Oct 20, 20256-KForeign issuer reportDocumentIndex
Sep 30, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Sep 4, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 20, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 12, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 7, 20256-KForeign issuer reportDocumentIndex